Item 5. Market for Registrant’s Common Equity
ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
The Company’s common stock is listed and traded on the NYSE under the ticker symbol “MED.”
Dividends
While historically the Company declared and paid dividends on the Company’s common stock, in December 2023, it announced the discontinuation of dividends to support investments in technology and future growth. Declaration and payment of dividends on the Company’s common stock are subject to the discretion of our board of directors and compliance with applicable laws. The decision to declare and pay dividends in the future will depend on general business conditions, the effect of such payments on our financial condition and other factors the Company’s board of directors consider relevant.
Holders
There were approximately 66 record holders of the Company’s common stock as of February 11, 2025. This number does not include beneficial owners of our securities held in the name of nominees.
Securities Authorized for Issuance Under Equity Compensation Plans
See Part III, Item 12 - Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters for information regarding securities authorized for issuance under our equity compensation plans, which information is incorporated herein by reference.
Issuer Purchases of Equity Securities
The following table provides information about the Company’s repurchases of common stock for the three months ended December 31, 2024:
2024 Total Number of Shares Purchased (1)
Average Price Paid per Share Total Number of Shares Purchased as Part of a Publicly Announced Plan or Program Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs (2)
October 1 - October 31 79 $ 19.22 — 1,323,568
November 1 - November 30 — — — 1,323,568
December 1 - December 31 — — — 1,323,568
____________________
(1) All of the shares of the Company’s common stock reflected in this column were surrendered by employees and directors to the Company to cover minimum tax liability withholding obligations upon the exercise of stock options or the vesting of shares of restricted stock and performance-based share awards previously granted to such employees and directors.
(2) At the outset of the quarter ended December 31, 2024, there were 1,323,568 shares of the Company's common stock eligible for repurchase under the repurchase authorization dated September 16, 2014 (the "Stock Repurchase Plan").
As of December 31, 2024, there were 1,323,568 shares of the Company’s common stock eligible for repurchase under the Stock Repurchase Plan. There can be no assurances as to the amount, timing or prices of repurchases, which may vary based on market conditions and other factors. The Stock Repurchase Plan does not have an expiration date and can be modified or terminated by the Board of Directors at any time.
Performance Graph
The following line graph compares the yearly percentage change in the Company’s cumulative total stockholder return (Common Stock price appreciation plus dividends, on a reinvested basis) for the last five fiscal years to that of the Standard & Poor’s 600 Consumer Staples Index and the Company’s selected peer group.
30
Table of Contents
2020 2021 2022 2023 2024
Medifast, Inc. $ 186.18 $ 203.61 $ 117.46 $ 72.43 $ 18.98
Benchmarking Peer Group 140.71 158.05 106.53 101.38 98.16
S&P 600 Consumer Staples 111.14 143.15 133.89 153.95 155.83
Medifast, Inc. Peer Group
1-800-flowers.com
McCormick & Company, Inc.
B&G Foods, Inc.
Nu Skin Enterprises, Inc.
BellRing Brands, Inc.
Spectrum Brands Holdings, Inc.
Duluth Holdings Inc.
The Hain Celestial Group, Inc.
Edgewell Personal Care Company
The Simply Good Foods Co.
Etsy, Inc.
Tupperware Brands Corp.
Herbalife Nutrition Ltd.
USANA Health Sciences, Inc.
Inter Parfums, Inc.
WW International, Inc.
ITEM 6. [RESERVED]
Not applicable.